U. Yörüker
University of Giessen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by U. Yörüker.
The Journal of Thoracic and Cardiovascular Surgery | 2016
Can Yerebakan; K. Valeske; H. Elmontaser; U. Yörüker; Matthias Mueller; Josef Thul; V. Mann; Heiner Latus; Anika Villanueva; Karoline Hofmann; Dietmar Schranz; Hakan Akintuerk
OBJECTIVE This retrospective study presents our operative results, mortality, and morbidity with regard to pulmonary artery growth and reinterventions on the pulmonary artery and aortic arch, including key features of our institutional standards for the 3-stage hybrid palliation of patients with hypoplastic left heart syndrome. METHODS Between June 1998 and February 2015, 182 patients with hypoplastic left heart structures underwent the Giessen hybrid stage I procedure. Among these, 126 patients with hypoplastic left heart syndrome who received a univentricular palliation or heart transplantation were included in the main analysis. Median age and body weight of patients at hybrid stage I were 6 days (0-237) and 3.2 kg (1.2-7), respectively. Comprehensive stage II operation was performed at 4.5 months (2.9-39.5), and Fontan completion was established at 33.7 months (21.1-108.2). Operative and interstage mortality, morbidity, growth and reinterventions on the pulmonary arteries, and long-term operative results of the aortic arch reconstruction were assessed. RESULTS Median follow-up time after Giessen hybrid stage I palliation was 4.6 years (0-16.8). Operative mortality at hybrid stage I, comprehensive stage II, and Fontan completion was 2.5%, 4.9%, and 0%, respectively. Cumulative interstage mortality was 14.2%. At 10 years, the probability of survival is 77.8%. Body weight (<2.5 kg) and aortic atresia had no significant impact on survival. McGoon ratio did not differ at comprehensive stage II and Fontan completion (P = .991). Freedom from pulmonary artery intervention was estimated to be 32.2% at 10 years. Aortic arch reinterventions were needed in 16.7% of patients; 2 reoperations on the aortic arch were necessary. CONCLUSIONS In view of the early results and long-term outcome, the hybrid approach has become an alternative to the conventional strategy to treat neonates with hypoplastic left heart syndrome and variants. Further refinements are warranted to decrease patient morbidity.
Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual | 2018
U. Yörüker; H. Akintürk
This article reviews our experience using hybrid stage I palliation in the neonatal period and subsequently with comprehensive stage II palliation for hypoplastic left heart syndrome. Between June 1998 and April 2017, 154 patients with the diagnosis of hypoplastic left heart syndrome and variants underwent a hybrid stage I palliation (bilateral pulmonary artery banding and ductal stenting). One hundred thirty-nine patients could be further univentricularly palliated. One hundred twenty-one patients underwent a comprehensive stage II operation with an operative mortality of 6.6%. The hybrid procedure provides reproducible results with reduced in-hospital, interstage, and long-term mortality and lower rates of aortic arch reinterventions.
The Journal of Thoracic and Cardiovascular Surgery | 2015
U. Yörüker; Can Yerebakan; Matthias Mueller; H. Akintürk
Thoracic and Cardiovascular Surgeon | 2018
U. Yörüker; K. Valeske; M. Müller; Christian Jux; S.-H. Bedriye; A. Sprengel; A. Hakan
Thoracic and Cardiovascular Surgeon | 2018
H. Akintürk; B. Sen-Hild; U. Yörüker; M. Müller; Josef Thul; Christian Jux; Dietmar Schranz
Thoracic and Cardiovascular Surgeon | 2018
K. Valeske; D. Dort; K. Gummel; M. Müller; U. Yörüker; Christian Jux; H. Akintürk
Thoracic and Cardiovascular Surgeon | 2018
U. Yörüker; K. Valeske; M. Müller; B. Sen-Hild; A. Sprengel; Christian Jux; H. Akintürk
Thoracic and Cardiovascular Surgeon | 2017
U. Yörüker; K. Valeske; H. Elmontaser; M. Müller; Josef Thul; Dietmar Schranz; H. Akintürk
Thoracic and Cardiovascular Surgeon | 2016
K. Selzer; C. Yerebakan; U. Yörüker; K. Valeske; H. Elmontaser; M. Müller; D. Schranz; H. Akintürk
Thoracic and Cardiovascular Surgeon | 2016
U. Yörüker; C. Yerebakan; H. Elmontaser; K. Valeske; M. Müller; I. Voges; D. Schranz; H. Akintürk